
|Articles|November 1, 2000
Supplements and Featured Publications
- Clinical and Economic Impact of Low-Molecular Weight Heparins in Managed Care
- Volume 6
- Issue 20 Suppl
CME/CPE Quiz
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
Introductionabout 25 years ago
Overview of Enoxaparin in the Treatment of DVTabout 25 years ago
DVT and Pulmonary Embolism in the Perioperative Patientabout 25 years ago
CME/CPE Article: Economics of Low-Molecular Weight Heparinsabout 25 years ago
Selected AbstractsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
3
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
4
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
5
















































